Volume 17, Number 10—October 2011
Granulicatella adiacens and Early-Onset Sepsis in Neonate
To the Editor: Granulicatella and Abiotrophia, formerly known as nutritionally variant streptococci, are normal flora of the human upper respiratory, gastrointestinal, and urogenital tracts (1). G. adiacens has been associated with bacteremia and endovascular, central nervous system, ocular, oral, bone and joint, and genitourinary infections (1–4).
Although streptococci are a frequent cause of early-onset sepsis in newborns, non–group B or D streptococci comprise only ≈1% of cases of early-onset neonatal sepsis; the condition is primarily associated with viridans streptococci (5). This report describes a male infant with early-onset sepsis caused by G. adiacens. Molecular genetic studies identified the same organism in flora isolated from the maternal cervix, which suggests vertical transmission.
After 36 weeks’ gestation, a male infant, weighing 2,850 g, was born by repeat caesarean section to a 37-year-old woman who was negative for group B streptococcus; she began labor without rupture of membranes. Apgar scores were 9 and 9 at 1 and 5 minutes, respectively. Respiratory distress developed in the infant within an hour of birth. Peripheral blood and cerebrospinal fluid (CSF) samples were obtained, and intravenous ampicillin (150 mg/kg every 12 h) and gentamicin (4 mg/kg every 24 h) were administered. Leukocyte count was 27,000/mm3 with 79% polymorphonuclear leukocytes and 2% band forms; platelet count was 223,000/mm3. CSF cell counts were 3 leukocytes/mm3 and 18 erythrocytes/mm3.
Respiratory distress progressed rapidly, and at 20 hours of life, mechanical ventilation was instituted. Chest radiograph demonstrated diffuse, bilateral interstitial infiltrates consistent with pneumonia. Persistent pulmonary hypertension was diagnosed by echocardiography. Peripheral blood culture yielded G. adiacens (API 20 STREP, bioMérieux Clinical Diagnostics, Durham, NC, USA) that was sensitive to vancomycin. Repeat blood samples were obtained before and after antimicrobial drug treatment was changed to vancomycin, 10 mg/kg every 12 h, and gentamicin, 4 mg/kg every 24 h. CSF culture and repeat blood cultures had no growth. Vancomycin and gentamicin were administered for 14 days. The patient eventually recovered and was discharged after 25 days of hospitalization. The biochemical identification of G. adiacens in the blood culture was confirmed by 16S rRNA gene sequencing.
Cervical samples for culturing were obtained from the mother 4 days after delivery. After samples were plated on blood and chocolate agar, colonies were harvested from the primary plates, and pooled bacterial DNA was isolated for further analyses. A primer pair was designed to amplify a 422-bp fragment unique to G. adiacens. These primers (sense, 5′-GGTTTATCCTTAGAAAGGAGGT-3′, and antisense, 5′-GAGCATTCGGTTGGGCACTCTAG-3′) were used to amplify G. adiacens from DNA prepared from the bacterial pools isolated from maternal cervix and, as control, from DNA prepared from the infant’s blood culture isolate. DNA amplicons underwent agarose gel electrophoresis with ethidium bromide staining and were visualized under ultraviolet light. PCR amplification showed DNA amplicons for the patient’s blood culture, his mother’s cervical swab sample, and a positive control but not for negative controls (Figure). Capillary nucleotide DNA sequence analysis confirmed all 3 amplicons as G. adiacens (not shown).
Nutritionally variant streptococci have been difficult to identify because they have unique culture requirements, they exhibit pleomorphic phenotypic features (1), and they demonstrate satellitism around colonies of other bacteria. This has led to misidentification or nonidentification by using commercially available phenotypic testing, prompting the recommendation that 16S rRNA gene sequencing be used for G. adiacens identification (6).
The Clinical and Laboratory Standards Institute does not recommend disk diffusion testing to determine the susceptibility of G. adiacens to antimicrobial drugs and suggests broth microdilution MIC testing in cation-adjusted Mueller-Hinton broth with 2.5%–5% lysed horse blood and 0.001% pyridoxine hydrochloride (7,8). Under these conditions, 55% of G. adiacens isolates were susceptible to penicillin, 63% were susceptible to ceftriaxone, 96% were susceptible to meropenem, and 100% were susceptible to vancomycin (4). A more recent report indicates that the resistance of G. adiacens to β-lactam and macrolide antimicrobial drugs may be increasing (3).
Treatment of G. adiacens infection may be difficult. In vitro antimicrobial drug susceptibility patterns do not correlate well with clinical response to treatment, and G. adiacens infections often respond poorly to antimicrobial drug treatment. Higher rates of bacteriologic failure and relapse rates after treatment have been observed for G. adiacens infection than for infections with streptococci and other related genera (9). G. adiacens endocarditis has been associated with a more severe clinical course than endocarditis caused by enterococci or viridans group streptococci, with higher rates of illness and death. On the basis of studies demonstrating synergy in vitro and in vivo, empiric combination therapy with vancomycin and an aminoglycoside has been suggested until susceptibility data are available (10), particularly when treating serious conditions such as endocarditis (3).
Reports have increased of serious infections caused by Granulicatella and Abiotrophia, including this report of early-onset neonatal sepsis due to G. adiacens. One recent study described 8 isolates associated with invasive infection in a 4-year period (3). Increased awareness and identification of G. adiacens are likely contributing to this increased recognition, with earlier cases not detected or diagnosed. 16S rRNA gene sequencing may facilitate or confirm Granulicatella and Abiotrophia spp. as the etiologic agents of infection.
- Christensen JJ, Facklam RR. Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol. 2001;39:3520–3.
- Gensheimer WG, Reddy SY, Mulconry M, Greves C. Abiotrophia/Granulicatella tubo-ovarian abscess in an adolescent virginal female. J Pediatr Adolesc Gynecol. 2010;23:e9–12.
- Zheng X, Freeman AF, Villafranca J, Shortridge D, Beyer J, Kabat W, Antimicrobial susceptibilities of invasive pediatric Abiotrophia and Granulicatella isolates. J Clin Microbiol. 2004;42:4323–6.
- Tuohy MJ, Procop GW, Washington JA. Antimicrobial susceptibility of Abiotrophia adiacens and Abiotrophia defectiva. Diagn Microbiol Infect Dis. 2000;38:189–91.
- Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928–2003. Pediatrics. 2005;116:595–602.
- Woo PC, Fung AM, Lau SK, Chan BY, Chiu SK, Teng JL, Granulicatella adiacens and Abiotrophia defectiva bacteraemia characterized by 16S rRNA gene sequencing. J Med Microbiol. 2003;52:137–40.
- Jorgensen JH, Hindler JF. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis. 2007;44:280–6.
- Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline–second edition. 30: (M45–A2). Wayne (PA): The Institute; 2010.
- Stein DS, Nelson KE. Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma. Rev Infect Dis. 1987;9:908–16.
- Bouvet A. Human endocarditis due to nutritionally variant streptococci: Streptococcus adjacens and Streptococcus defectivus. Eur Heart J. 1995;16(Suppl B):24–7.
Suggested citation for this article: Bizzarro MJ, Callan DA, Farrel PA, Dembry L-M, Gallagher PG. Granulicatella adiacens and early-onset sepsis in neonate [letter]. Emerg Infect Dis [serial on the Internet]. 2011 Oct [date cited]. http://dx.doi.org/10.3201/eid1710.101967
- Page created: September 27, 2011
- Page last updated: September 27, 2011
- Page last reviewed: September 27, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)